Steadynwise Posted - 38 minutes ago

@Greyhound14 check out the 2 recent PR from $AVXL AND $SAVA on their phase 2 equivalent result. AVXL reported p-values to show their confidence on statistical significance result. While on the other hand, SAVA highlighted their result were not significant due to their sample size !!!?? What kind of clinical study was that??! I better play safe on AVXL https://www.anavex.com/post/anavex-sphase2b-3trialofblarcamesine-anavex-2-73-inpatientswithalzheimer-sdisease https://www.cassavasciences.com/news-releases/news-release-details/oral-simufilam-slowed-cognitive-decline-randomized-withdrawal

georgejjl Posted - 55 minutes ago

$AVXL Monday will be an interesting day for AVXL stock, after Dr. Sabbagh's presentation at the AAIC meeting on Sunday. Good luck and GOD bless,

Sand_Pebble Posted - 1 hour ago

$AVXL At dayisthebest "Do we have a big enough trial to get ema approval" is a good question but not necessarily the question to ask. The question should be, "Is blarcamesine a safer drug than the ones being denied & considered by EMA?". A: Yes. With conditional approval in Canada, Retts & OLE studies, patients have been safely taking Blarcamesine for nearly 5 yrs now. With ema denying Alzheimer treatment while the US approving, what type of pressure do you think the public & lawmakers are putting on EMA for an urgently needed, cost effective Alzheimers treatment? It doesn't matter if Blarcamesine was the placebo used during the Leqembi and Elli drug because no one died on the placebo. Anything is better than a brain bleed death drug.

Steadynwise Posted - 2 hours ago

$AVXL good analysis article in 2022 on Aduhelm & Lecanemab & Blarcamesine https://www.sotcanalytics.com/archive-2022/update-compendium#h.8zge6ud7q0ba

Logic102 Posted - 3 hours ago

$AVXL The SEC is totally ineffective. It's so obvious that without $7 expiring options today that we were on track for a 10% gain with the Leqembi news out of Europe and our European connections. Blatant Market Manipulation: they don't even have to hide it anymore. It won't matter a lick in the long run and I had no options, but it still ticks me off.

Logic102 Posted - 3 hours ago

$AVXL Moronic comment of the day "rug pull next week" blocked. Also blocked the moron who said today proves SAVA is the winner based on today. I wish I could block the Market Manipulators who have the Big Money that kept our share price down today so they would not have to pay folks who had $7 options expiring today. Coincidence? Nope, the small investor does not have a level playing field. No worries, just buy shares.

Sand_Pebble Posted - 3 hours ago

$AVXL Donanemab has worse side effects & worse percentages than Leqembi which was denied by EMA today. Even if Blarcamesine was just a sugar pill placebo it would be better than those two. I suspect Blarcamesine will be the only new EU approved Alzheimer drug on the EU market. If a drug manufacturer ran trails on a renamed aspirin after reviewed Donanemab & Leqembi it would be approved for the treatment of Alzheimers.

stjernerogvann Posted - 4 hours ago

$AVXL has anyone any info about the after-hours presentation by Anavex at the Rett conference?

buyhiselow Posted - 4 hours ago

$AVXL rug pull next week?

tripoli99 Posted - 4 hours ago

$AVXL what do we expect from earnings? Anyone plugged into that with some insight?

dayisthebest Posted - 5 hours ago

$AVXL i hope we dont get blinded sided like retts go up to $10 then hit hard loss big. will this be the time. do we have a big enough trial to get ema approval or will they ask for another trial with more. just seem you need to know when ti exit as it has shown in the past to go up but give back all gains

ExecGolf Posted - 5 hours ago

$AVXL Unable to ride SAVA’s coattails today.

Earlbefree Posted - 5 hours ago

$AVXL nothing wrong with today, 7 or 8% profit taking off the high, weve been on nice run, primed and ready for Monday

papatrick Posted - 7 hours ago

$AVXL added more than 100 followers this week, am i right? Welcome to all newbies here. Will all be rich together soon, around the corner!

AVXL4theWin Posted - 7 hours ago

$AVXL

CatPot Posted - 7 hours ago

$AVXL started off great today but weak ending

lookupdownside Posted - 8 hours ago

$AVXL shorts threw almost 100k shares in last three minutes of trading…I wish they get burnt soon ..

Filldagap Posted - 8 hours ago

$AVXL If anyone is inclined to share some updates from the activities this weekend please feel free. Thanks

Itinerant Posted - 8 hours ago

$AVXL Maybe the shorts are getting into position for an assumed sell the news on Monday. I am just guessing.

5RingsPatsRule Posted - 8 hours ago

$AVXL I do not believe that nothing has leaked.... I do believe that the right people know which is why we are treading water today. They don't want to show their hand.

papatrick Posted - 8 hours ago

$AVXL of course sava increases today, as puts are closing and paying their holders, same here but for calls. For ANVS...its something else I presume??

TheRockery Posted - 8 hours ago

$AVXL $SAVA $ANVS I own all 3 on different amounts!! All will succeed in their own way!!! LFG!!!

Factanonverba Posted - 9 hours ago

$AVXL AZ product with the highest potential. Biogen out in Europe.

Logic102 Posted - 9 hours ago

$AVXL is the clear winner based on the one month and 3 month charts If SAVA was the winner it's stock price would have doubled or tripled today.

Goodhealth Posted - 9 hours ago

$AVXL Perhaps it is quite good that the situation is as it is!... If the shorts do not manage to get out at a low share price, then when they want to get out, they will contribute to a very high share price when the good news comes, and it might be even better for us.

Greyhound14 Posted - 9 hours ago

$AVXL The market clearly believes that Cassava is the big winner from today's news in Europe, and will be the drug of choice for European providers. Let's see what this weekend brings in terms of new information, if anything.

Logic102 Posted - 10 hours ago

$AVXL Market manipulators don't want to pay out on $7 calls today so get your shares below $7 while you can.

Rickyrickz70 Posted - 10 hours ago

$AVXL $CGTX Leqembi has been rejected by the EMA today and if you can remember, the FDA approval was controversial. The clinic needs Alzheimer drugs that are based on different mechanisms than amyloid plaque clearance

Trainguy1 Posted - 10 hours ago

$AVXL There are by far more $7 calls expiring today than any other options, so we can be pretty sure the SP won't go over $7 this afternoon.

great_tree Posted - 10 hours ago

$AVXL Andrew Left indicted.